More Money, Less Cure: Why Global Health Assistance Needs Restructuring

Ethics and International Affairs

Volumn 23, Issue 3, 2009, Pages 225-234

  Esser, Daniel E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950775690     PISSN: 08926794     EISSN: 17477093     Source Type: Journal    
DOI: 10.1111/j.1747-7093.2009.00214.x     Document Type: Article

References (22)

1. Landis MacKellar, “Priorities in Global Assistance for Health, AIDS, and Population,” Population and Development Review 31, no. 2 (2005), pp. 293–312.
2. David Canning, “Priority Setting and the ‘Neglected’ Tropical Diseases,” Transactions of the Royal Society of Tropical Medicine and Hygiene 100 (June 2006), pp. 499–504.
3. Daniel E. Esser and Kara Keating Bench, “Funding Foci, Effectiveness Proxies and Recipients' Priorities for Global Health Assistance: Are U.S. Foundations More Responsive Than Official Development Assistance?” World Development (forthcoming).
4. Gill Walt, Health Policy: An Introduction to Process and Power (London: Zed Books, 1994).
5. Christopher J. L. Murray et al., “Effectiveness and Costs of Interventions to Lower Systolic Blood Pressure and Cholesterol: A Global and Regional Analysis on Reduction of Cardiovascular-Disease Risk,” Lancet 361 (March 2003), pp. 717–725
6. Timothy Powell-Jackson et al, “Countdown to 2015: Tracking Donor Assistance to Maternal, Newborn, and Child Health,” Lancet 368 (September 2006), pp. 1077–87
7. and Justin Parkhurst, “The Crisis of AIDS and the Politics of Response: The Case of Uganda,” International Relations 15, no. 6 (2001) pp. 69–87.
8. Lawrence Gostin, “Why Rich Countries Should Care About the World's Least Healthy People,” Journal of the American Medical Association 298, no. 1 (2007), pp. 89–92.
9. Congressional Budget Office, “A Potential Influenza Pandemic: Possible Macroeconomic Effectsand Policy Issues” (December 8, 2005; revised July 27,2006); available at www.cbo.gov/ftpdocs/69xx/doc6946/12–08-BirdFlu.pdf (accessed June 23, 2009).
10. Helen Epstein, The Invisible Cure: Why We Are Losing the Fight Against AIDS in Africa (New York: Picador, 2007).
11. “The Price of Good Deeds,” Economist, February 21, 2008.
12. Jeremy Shiffman, “Donor Funding Priorities for Communicable Disease Control in the Developing World,” Health Policy and Planning 21, no. 6 (2006), pp. 411–420.
13. Health Policy and Planning.
14. Esser and Keating Bench, “Funding Foci.”
15. David P. Fidler, “Reflections on the Revolution in Health and Foreign Policy,” Bulletin of the World Health Organization 85, no. 3 (2007), p. 243.
16. International Evaluation Group, Improving Effectiveness and Outcomes for the Poor in Health, Nutrition, and Population: An Evaluation of World Bank Group Support Since 1997 (Washington, D.C.: International Bank for Reconstruction and Development, 2009).
17. Jürgen Habermas, The Theory of Communicative Action (1)—Communication and Evolution of Society (Boston: Beacon Press, 1984)
18. and Andreas Rasche and Daniel E. Esser, “From Stakeholder Management to Stakeholder Accountability: Applying Habermasian Discourse Ethics to Accountability Research,” Journal of Business Ethics 65 (2006), pp. 251–267.
19. Powell-Jackson et al., “Countdown to 2015”
20. and Esser and Keating Bench, “Funding Foci.”
21. Catriona Waddington, “Does Earmarked Donor Funding Make It More or Less Likely That Developing Countries Will Allocate Their Resources Towards Programmes That Yield the Greatest Health Benefits?” Bulletin of the World Health Organization 82, no. 9 (2004), pp. 703–708.
22. Gorik Ooms et al., “The ‘Diagonal’ Approach to Global Fund Financing: A Cure for the Broader Malaise of Health Systems?” Globalization and Health 4, no. 6 (2008).